³Ô¹ÏÍøÕ¾

Latest cell therapy News | Page 2

HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
High-resolution map of the human placenta reveals COVID virus hideouts
Cynata Therapeutics announces CEO succession and board changes
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
Light On Horizon For New Eye Clinical Trials
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Chimeric Therapeutics announces new capital raise
CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial
Advanced immunotherapy treatment may hold promise for children with brain cancer
Carina Biotech to present details of planned trial of CAR-T cell therapy candidate
HKUST Sweeps 20 awards at 48th International Exhibition of Inventions Geneva
AstraZeneca advances its pipeline and highlights progress in immuno-oncology, ADCs, cell therapy and epigenetics at AACR
Cynata receives ethics approval for proposed aGvHD Phase 2 clinical trial
Surprise finding shows neutrophils can fight tumors
Chimeric Therapeutics reports ‘positive feedback’ on plan for CHM 2101
Chimeric Therapeutics advances manufacture of CHM 2101 viral vector
GreenLight Clinical and Cure Therapeutics look to future collaboration
Chimeric Therapeutics updates on CLTX CAR T clinical trial
Scientists Create Conditions for Stem Cell Growth Similar to Human Embryos
Scientists use materials to make stem cells behave like human embryos
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
Generosity drives research forward
High appetite for biotech VC cited in new report
Goldilocks treatment window could lead to cancer therapy without harmful side-effects
Philanthropy accelerates stroke trials
$270 million to accelerate med tech innovation
Australians call for equitable access to new era in fighting cancer
Immune therapy targets cells that cause leukemia relapse
Cynata Therapeutics adds new site for MEND clinical trial
Key protein facilitates regeneration of liver blood vessels
Potential new Covid immunotherapy could protect vulnerable
Programming Immune System to Supercharge Cancer Cell Therapies
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
Arovella Therapeutics closes over-subscribed share purchase plan
Treating type 1 diabetes with stem cell replacement therapy
Placental cell therapy could deliver new treatment options for liver disease
Researchers working on injection-free cell therapy for diabetes
QIMR Berghofer attracts support for potential multiple sclerosis treatment
QIMR Berghofer signs licensing, research and manufacturing deal for new cellular immunotherapy with US company Cellevolve Bio
Early intervention treatment for cerebral palsy shows promise despite sex differences
New mothers could help protect other babies’ brains
Highly Cited Researchers 16 November
Ludwig Lausanne team devises method to selectively grow tumor-targeting T cells for cancer therapy
Pelvic organ prolapse treatment attracts international award
Final ‘foundation stones’ set for future of Australian regenerative medicine
Cloaking technology: helping therapeutic cells evade your immune system
Cynata Therapeutics announces publication of new paper